EMAIL THIS PAGE TO A FRIEND

The Journal of neuroscience : the official journal of the Society for Neuroscience

Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons.


PMID 25009264

Abstract

Substantia nigra dopamine neurons are involved in behavioral processes that include cognition, reward learning, and voluntary movement. Selective deterioration of these neurons is responsible for the motor deficits associated with Parkinson's disease (PD). Aging is the leading risk factor for PD, suggesting that adaptations occurring in dopamine neurons during normal aging may predispose individuals to the development of PD. Previous studies suggest that the unique set of ion conductances that drive spontaneous, rhythmic firing of action potentials could predispose substantia nigra dopamine neurons to selective neurodegeneration. Here we show, using patch-clamp electrophysiological recordings in brain slices, that substantia nigra dopamine neurons from mice 25-30 months of age (old) have comparable membrane capacitance and input resistance to neurons from mice 2-7 months of age (young). However, neurons from old mice exhibit slower firing rates, narrower spike widths, and more variable interspike intervals compared with neurons from young mice. Dopamine neurons from old mice also exhibit smaller L-type calcium channel currents, providing a plausible mechanism that likely contributes to the changes in impulse activity. Age-related decrements in the physiological function of dopamine neurons could contribute to the decrease in voluntary movement and other dopamine-mediated behaviors observed in aging populations. Furthermore, as pharmacological antagonism of L-type calcium channels has been proposed as a potential treatment for the early stages of PD, our results could point to a limited temporal window of opportunity for this therapeutic intervention.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

T48402
2,2,2-Tribromoethanol, 97%
C2H3Br3O
A4036
Adenosine, suitable for cell culture, BioReagent
C10H13N5O4
01890
Adenosine
C10H13N5O4
A0230200
Adenosine, European Pharmacopoeia (EP) Reference Standard
C10H13N5O4
PHR1138
Adenosine, Pharmaceutical Secondary Standard; Certified Reference Material
C10H13N5O4
A1289
Apamin, from bee venom, ≥95% (HPLC)
C79H131N31O24S4
A9459
Apamin, synthetic, ≥97% (HPLC)
C79H131N31O24S4
439800
Cadmium chloride, anhydrous, beads, −10 mesh, 99.999% trace metals basis
CdCl2
202908
Cadmium chloride, 99.99% trace metals basis
CdCl2
655198
Cadmium chloride, technical grade
CdCl2
746487
Cesium chloride, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, 99.9%
ClCs
203025
Cesium chloride, ≥99.999% trace metals basis
ClCs
449733
Cesium chloride, anhydrous, beads, −10 mesh, 99.999% trace metals basis
ClCs
289329
Cesium chloride, ReagentPlus®, 99.9%
ClCs
C3139
Cesium chloride, optical grade, ≥99.5% trace metals basis
ClCs
C3011
Cesium chloride, Grade I, ≥99.0%
ClCs
562599
Cesium chloride, 99.99% trace metals basis
ClCs
562602
Cesium chloride, Cabot high-purity grade
ClCs
C3032
Cesium chloride, for molecular biology, ≥99% (silver nitrate titration)
ClCs
C4036
Cesium chloride, for molecular biology, ≥98%
ClCs
C3309
Cesium chloride, BioXtra, ≥99.5% (titration)
ClCs
C6914
Cesium chloride, Grade II, ≥98%
ClCs
20966
Cesium chloride, BioUltra, for molecular biology, ≥99.5% (AT)
ClCs
20967
Cesium chloride, BioUltra, ≥99.0% (AT)
ClCs
31807
Cesium chloride, puriss. p.a., ≥99.5%
ClCs
D0540
DNQX, ≥98% (TLC)
C8H4N4O6
G6752
Guanosine, ≥98%
C10H13N5O5
G6264
Guanosine, suitable for cell culture, BioReagent
C10H13N5O5
75903
Guanosine, ≥97.0% (HPLC)
C10H13N5O5
H2138
Hexamethonium chloride, solid (hygroscopic)
C12H30Cl2N2